Author:
Tarighi Parastoo,Eftekhari Samane,Chizari Milad,Sabernavaei Mahsa,Jafari Davod,Mirzabeigi Parastoo
Reference192 articles.
1. A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia (COVACTA). https://clinicaltrials.gov/ct2/show/NCT04320615.
2. Remdesivir as a possible therapeutic option for the COVID-19;Al-Tawfiq;Trav. Med. Infect. Dis.,2020
3. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases;Al‐Bari;Pharma Res Per,2017
4. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect;Andreani;Microb. Pathog.,2020
5. Mechanism of darunavir (DRV)’s high genetic barrier to HIV-1 resistance: a key V32I substitution in protease rarely occurs, but once it occurs, it predisposes HIV-1 to develop DRV resistance;Aoki;mBio,2018
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献